<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03317535</url>
  </required_header>
  <id_info>
    <org_study_id>2017-10-15</org_study_id>
    <nct_id>NCT03317535</nct_id>
  </id_info>
  <brief_title>Choice of Anesthesia for Endovascular Treatment of Acute Ischemic Stroke in Posterior Circulation</brief_title>
  <acronym>CANVAS-II</acronym>
  <official_title>Choice of Anesthesia for Endovascular Treatment of Acute Ischemic Stroke in Posterior Circulation: a Randomized Controlled Exploratory Study (CANVAS-Ⅱ)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Tiantan Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Tiantan Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There is few randomized controlled clinical to investigated the impact of anesthetic type on
      outcome in patients with acute ischemic stroke in posterior cerebral circulation. It is
      unknown whether the choice of anesthesia is impacted on the outcomes for these patients or
      not. The investigators will perform a randomized controlled pilot clinical trial of general
      anesthesia versus local anesthesia/conscious sedation to explore and find out a potential
      fact whether anesthetic type alters perioperative neurological function in patients with
      acute ischemic stroke in posterior cerebral circulation.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2018</start_date>
  <completion_date type="Anticipated">March 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>modified rankin score（mRS）</measure>
    <time_frame>post-procedural 90 days</time_frame>
    <description>Modified rankin score（mRS）is used to evaluate the primary outcome. The scale of mRS is 0 to 6. The best neurological outcome is the mRS with 0, indicating no any symptom left, and a good neurological outcome is agreed with a mRS≤2. mRS of 6 is the worst, indicating death. mRS will be evaluated by outcomes assessor who is blinded to the grouping.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>Posterior Circulation Brain Infarction</condition>
  <arm_group>
    <arm_group_label>Local anesthesia/conscious sedation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients will be injected by propofol (adjusted by bispectral index scale ≥70 ) and /or remifentanil（0.01-0.06μg/kg/min）. Patients will maintain spontaneous breathing.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>General anesthesia</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Patients will be induced with remifentanil (0.2-0.8 μg/kg), propofol (1-2mg/kg) and rocuronium (0.6 mg/kg). Anesthesia will then be maintained keep the BIS between 40 and 60 with propofol and remifentanil. After tracheal intubation, patients will be kept with controlled ventilation.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>General anesthesia</intervention_name>
    <description>Patients will be injected with propofol, remifentanil and muscular relaxant with controlled ventilation.</description>
    <arm_group_label>General anesthesia</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Local anesthesia/concious sedation</intervention_name>
    <description>Patients will be injected with propofol and remifentanil.</description>
    <arm_group_label>Local anesthesia/conscious sedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Spontaneous breath</intervention_name>
    <description>Patients will be kept spontaneous breath.</description>
    <arm_group_label>Local anesthesia/conscious sedation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Controlled ventilation</intervention_name>
    <description>Patient will be kept with controlled ventilation.</description>
    <arm_group_label>General anesthesia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with acute ischemic stroke in posterior cerebral circulation scheduled to
             receive emergency endovascular treatment; Age &gt; 18; The onset time is within 24 hours;
             Modified rankin score ≤2 before onset.

        Exclusion Criteria:

          -  Radiological ambiguity concerning infarction and vessel occlusion; Additional
             intracerebral hemorrhage; Anterior circulation infraction; Coma on admission (Glasgow
             coma score less than 8); NIHSS less than 6 or more than 30; Severe agitation or
             seizures on admission; Obvious loss of airway protective reflexes and/or vomiting on
             admission; Being intubated before treatment on admission; Known allergy to anesthetic
             or analgesic;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>85 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ruquan Han, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Department of Anesthesiology, Beijing Tiantan Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Ruquan Han, M.D., Ph.D.</last_name>
    <phone>8610-67096660</phone>
    <email>ruquan.han@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing TianTan Hospital</name>
      <address>
        <city>Beijing</city>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ruquan Han, M.D., Ph.D</last_name>
      <phone>8610-67096660</phone>
      <email>ruquan.han@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>October 15, 2017</study_first_submitted>
  <study_first_submitted_qc>October 20, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2017</study_first_posted>
  <last_update_submitted>November 29, 2019</last_update_submitted>
  <last_update_submitted_qc>November 29, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beijing Tiantan Hospital</investigator_affiliation>
    <investigator_full_name>Yuming Peng</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Anesthesia Methods</keyword>
  <keyword>Acute Ischemic Stroke</keyword>
  <keyword>Endovascular Treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anesthetics</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

